A carregar...
Pyrazolo[1,5-a]pyrimidine TRPC6 Antagonists for the Treatment of Gastric Cancer
Transient receptor potential canonical 6 (TRPC6) proteins form receptor-operated Ca(2+)-permeable channels, which have been thought to bring benefit to the treatment of diseases, including cancer. However, selective antagonists for TRPC channels are rare and none of them has been tested against gast...
Na minha lista:
| Publicado no: | Cancer Lett |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6345172/ https://ncbi.nlm.nih.gov/pubmed/29859875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2018.05.041 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|